Speaker illustration

Doctor Yu Hoshika

Nippon Medical School Teaching Hospital, Tokyo (Japan)

Effect of empagliflozin versus placebo on body composition in patients with acute myocardial infarction and type 2 diabetes mellitus: subgroup analysis of the EMBODY trial

Event: ESC Congress 2020

Topic: Pharmacotherapy

Session: Risk Factors and Prevention ePosters


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb